A carregar...
A randomized, comparative, open-label study of efficacy and tolerability of alfuzosin, tamsulosin and silodosin in benign prostatic hyperplasia
OBJECTIVES: Benign prostatic hyperplasia (BPH) is a common and progressive disease affecting elderly males, often associated with lower urinary tract symptoms (LUTS). α1-blockers are the mainstay in symptomatic therapy of BPH. Because of their greater uroselectivity and minimal hemodynamic effects,...
Na minha lista:
| Publicado no: | Indian J Pharmacol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications & Media Pvt Ltd
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4825428/ https://ncbi.nlm.nih.gov/pubmed/27127315 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.178825 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|